SOURCE: InoLife Technologies Inc.
30 Years of Experience and 40-Plus Successful Product Launchings Greatly Contributed to the Decision
RALEIGH, NC–(Marketwire – December 9, 2010) – InoLife Technologies, Inc. (
John O’Maley and Associates (JOA) provide over 30 years of experience in successfully launching over 40 consumer products into nearly every trade channel of the market. This company has a long-standing and trusted reputation in the retail industry in providing world-class sales presentations on products that result in significant sales and brand awareness.
John O’Maley, President of JOA, contributes his success from his training in sales and marketing, advertising and business development at Proctor & Gamble. That experience has proven to be instrumental in generating outstanding results for his clients. JOA also uses a proven national broker network that consists of over 30 key senior account sales executives who were trained in fortune 500 companies. This ensures continuity and excellent national coverage. For more information on JOA visit www.omaley.com
InoLife has considered many companies to use for this important aspect for the success in placing its current and future DNA-Based products into the consumer market. Management feels that John O’Maley and Associates has the experience and proven success record to get the job done. We look forward to working with John’s company.
About InoLife Technologies, Inc.
InoLife is poised to become one of the premier U.S. marketers of state-of-the-art DNA-based test products. Positioned for growth and success in a burgeoning market, InoLife Technologies, www.inolifetech.com, is primarily focused on products, services and solutions that will enable state-of-the-art healthcare for today and the future for a diverse base of customers and end users. The Company’s mission is to identify, develop, integrate and bring to market innovative healthcare-based products and services that provide timely and practical solutions. The primary products and services that InoLife is currently addressing focuses upon those specific products and services that provide key solutions through the innovative use of specific DNA testing and Genetic analysis systems.
The principal customers of InoLife’s products and services are healthcare providers, physicians, practitioners, hospitals and outpatient facilities. InoLife will be marketing and distributing its products through traditional distribution channels. Additionally InoLife has developed certain products that can be sold directly to consumers and has created specific programs to reach those customers including e-commerce, direct sales, healthcare providers, pharmacies, distributors, retail sellers and specialty retailers.
Forward-Looking Statements
Safe Harbor Statement under the Private securities Litigation Reform Act of 1995: The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements including, but not limited to, certain delays beyond the Company’s control with respect to market acceptance of new technologies, products and services, delays in testing and evaluation of products and services, and other risks detailed from time to time in the Company’s filings with the Securities and Exchange Commission.